Poly-e-Caprolactone/Fibrin-Alginate scaffold: a new Pro-Angiogenic composite biomaterial for the treatment of bone defects
Resumen: We hypothesized that a composite of 3D porous melt-electrowritten poly-ɛ-caprolactone (PCL) coated throughout with a porous and slowly biodegradable fibrin/alginate (FA) matrix would accelerate bone repair due to its angiogenic potential. Scanning electron microscopy showed that the open pore structure of the FA matrix was maintained in the PCL/FA composites. Fourier transform infrared spectroscopy and differential scanning calorimetry showed complete coverage of the PCL fibres by FA, and the PCL/FA crystallinity was decreased compared with PCL. In vitro cell work with osteoprogenitor cells showed that they preferentially bound to the FA component and proliferated on all scaffolds over 28 days. A chorioallantoic membrane assay showed more blood vessel infiltration into FA and PCL/FA compared with PCL, and a significantly higher number of bifurcation points for PCL/FA compared with both FA and PCL. Implantation into a rat cranial defect model followed by microcomputed tomography, histology, and immunohistochemistry after 4- and 12-weeks post operation showed fast early bone formation at week 4, with significantly higher bone formation for FA and PCL/FA compared with PCL. However, this phenomenon was not extrapolated to week 12. Therefore, for long-term bone regeneration, tuning of FA degradation to ensure syncing with new bone formation is likely necessary.
Idioma: Inglés
DOI: 10.3390/polym13193399
Año: 2021
Publicado en: Polymers 13, 19 (2021), 3399 [22 pp.]
ISSN: 2073-4360

Factor impacto JCR: 4.967 (2021)
Categ. JCR: POLYMER SCIENCE rank: 16 / 90 = 0.178 (2021) - Q1 - T1
Factor impacto CITESCORE: 5.7 - Materials Science (Q1)

Factor impacto SCIMAGO: 0.726 - Polymers and Plastics (Q1) - Chemistry (miscellaneous) (Q1)

Tipo y forma: Article (Published version)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2023-05-18-16:18:16)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2023-01-26, last modified 2023-05-19


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)